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CHAPTER 1: Introduction 
1.1: Pre-mRNA splicing is carried out by the spliceosome. Pre-mRNA splicing is the 
removal of non-coding sequences (introns) and the ligation of coding sequences 
(exons) via two transesterification reactions during the maturation to mRNA [1] (Fig. 1). 
During the first transesterification reaction, the 2’-hydroxyl group of the branch site 
adenosine attacks the 5’ splice site, and during the second transesterification reaction 
the free 3’ hydroxyl group of the 5’ exon attacks the 3’ splice site, ligating the two exons 
and releasing the intron as a lariat structure [1]. Pre-mRNA splicing is carried out by a 
multi mega-Dalton RNA-protein complex called the spliceosome [1]. Two different types 
of spliceosomes coexist in many eukaryotes; the more common U2-dependent 
spliceosome, which is the focus of this study, and the less abundant U12-dependent 
spliceosome [1]. The U2-dependent spliceosome consists of five snRNAs (U1, U2, U4, 
U5 and U6) and more than seventy proteins in yeast and about one-hundred proteins in 
humans [1-3].  
The structure and composition of the spliceosome change throughout the splicing 
reaction, making the spliceosome one of the most complex biological machines [4]. 
Splicing begins with the recognition of the 5’ splice site and branch site by U1 and U2 
snRNAs, respectively, to form the pre-spliceosome (Fig. 2). The tri-snRNP complex, 
U4/U6·U5, is then recruited to the pre-spliceosome generating the penta-snRNP 
structure called the pre-catalytic spliceosome (complex B). The DExD/H-box family 
helicases, Prp28 and Brr2, then cause a large-scale structural rearrangement in the 
spliceosome [1]. As a result, the U4/U6 duplex  is  unwound and  the  U6  snRNA  forms 
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base-pair interactions with U2. The U1/5’ splice-site interaction is also disrupted and 
replaced with a U6/5’ splice-site interaction, forming the activated spliceosome, (Bact) 
[1]. Bact is then converted to the catalytically activated spliceosome (B*) in a reaction 
mediated by the protein Prp2 [1]. After the first transesterification reaction, B* forms the 
complex C, which performs the second transesterification reaction to ligate the two 
exons and release the branched intron (Fig.2). The snRNAs can then be re-used in 
another splicing reaction. 
 
Figure 1: Two transesterification reactions occur during splicing [1]. First, the 2’-hydroxyl group of branch 
site adenosine (circled in red) attacks the 5’ splice site resulting a free 3’-OH of 5’ exon and a branched 
intron attached to the 3’ exon. Second, 3’-OH of the 5’ exon attacks the 3’ exon, ligating the two exons 
and removing the lariat intron. 
1.2: Only a few components are present at the active site of the spliceosome. 
Despite the complexity, only a few components are present in the active site of the 
spliceosome [5]. These include U2 and U6 snRNAs, as well as the U5 snRNP protein, 
Prp8 [5-7]. In the active spliceosome, U2 and U6 form extensive base pairs with each 
other (Fig. 3) and the branch  site  and  the  5’ splice site,  respectively.  High sequence  
3 
 
 
 
Figure 2: Assembly and the catalysis of the spliceosome. Exons and introns are shown in boxes and 
black lines respectively. Circles represent the five snRNAs. The U5 snRNP protein, Prp8, enters the cycle 
at complex B and remains attached until the end [8]. 
 
  
Figure 3: Alternative secondary structures adopted by the U2-U6 complex. The three-helix junction 
proposed by the Guthrie lab suggests that the invariant AGC triad (red) of U6 form intermolecular base 
pairs with U2 (Left) [9], while the four-helix junction proposed by the Butcher lab suggests AGC triad form 
intramolecular base pairs extending the U6 ISL (Right) [10]. 
conservation, structural similarity to the group II intron domain V (DV) [11], and genetic 
studies have lead to the proposal that U6 plays a catalytic role in pre-mRNA splicing. 
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Group II introns are self-splicing ribozymes that are present in certain bacteria [12], 
fungi and plants [13]. Both DV of group II introns and U6 snRNA contain an invariant 
AGC triad, GNRA-type loop, and a one- or two-nucleotide bulge in almost identical 
locations [5]. In U6 snRNA, the AGC triad is found to be important in both catalytic steps 
of splicing [14, 15]. The GNRA-type loop in the group II intron forms a tertiary interaction 
to properly position DV in the active site [16]. It is believed that the GNRA-type loop in 
the spliceosome is also involved in tertiary interactions to facilitate splicing [5]. Crystal 
structure and phosphorothioate substitution studies show that both bulge regions of DV 
and U6 ISL (A376-C377 of group II intron and U80 of U6 ISL) bind a metal ion that has 
been shown to be important for the catalysis [17-21]. These studies suggest that both 
group II introns and the spliceosome may have evolved from a common ancestor, and 
hence the spliceosome is a ribozyme [20, 22]. 
1.3: The U2-U6 complex adopts multiple conformations. The structure adopted by 
U2-U6 has been a matter of debate for the past few years. Yeast genetic studies from 
the Guthrie lab [9] suggest that the U6 AGC triad forms intermolecular base pairs with 
U2, and therefore, the U2-U6 complex adopts a three-helix junction (Fig. 3). On the 
other hand, mammalian genetic studies from the Manley lab [23] and early NMR studies 
carried out on a shorter construct from the Butcher lab suggest that the invariant AGC 
triad forms intramolecular base pairs, adopting a four-helix junction [10] (Fig. 3), while 
later NMR studies carried out on a longer U2-U6 construct suggest a three-helix 
junction [24].  
Previous smFRET studies carried out on a minimal U2-U6 construct from our lab 
showed that U2-U6 adopts at least three dynamic conformations with distinct FRET 
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states (~0.2, ~0.4 and ~0.6) [25]. The relative populations of the three FRET states 
revealed by smFRET are dependent on Mg2+ concentration [25]. With increasing Mg2+ 
concentration, the low FRET state populations are increased, while with decreasing 
Mg2+ concentrations, the high FRET states populations are increased. Furthermore, the 
ACAGAGA sequence, AGC triad, and U80 of U6 have been hypothesized to form base-
triple interactions that are proposed to stabilize the high FRET state (Fig. 4) [26]. It is 
hypothesized that when Mg2+ is bound, U80 is stacked into the helix [24], and therefore 
it can no longer participate in the base-triple formation, and hence, there is an increase 
in the population of the low FRET state. In contrast, when Mg2+ is not bound, U80 is 
flipped out from the U6 ISL, and the high FRET state is favored. According to this 
model, when Mg2+ is bound, the distance between the U6 ISL and the ACAGAGA 
sequence is increased, which in turn increase the distance between the bound metal ion 
and the 5’ splice site. Therefore, it is believed that with a constant supply of Mg2+ in 
vivo, protein factors may adjust the relative stability of the U2-U6 dynamic 
conformations to achieve efficient splicing [5, 24, 25]. 
1.4: The spliceosomal protein, Prp8, may play an important role in splicing 
catalysis. The idea that the spliceosome is a ribozyme has been challenged with the 
identification of the U5 snRNP protein, Prp8, which is one of the largest (2413 and 2335 
residues in yeast and human, respectively) [27] and well-conserved proteins found in 
the nucleus [28-30]. Of all the spliceosomal proteins, Prp8 is the only protein that 
extensively cross-links to the 5’ and 3’ splice sites of the substrate pre-mRNA, U5 and 
U6 snRNA [31, 32], indicating a catalytic or structural role of Prp8 in splicing [33]. 
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Studies have shown that Prp8 has several domains, such as a nuclear-localization 
domain (NLS), RNA recognition motif (RRM), Jab1/MPN domain, and an RNase H-like  
 
 
Figure 4: The proposed U2-U6 folding pathway. (A) Base-triples are proposed to stabilize the high FRET 
state. When Mg2+ is bound, the conformation is changed and U2-U6 goes to the low FRET state via an 
intermediate. (B) The proposed base-triple interactions between ACAGAGA sequence, AGC triad and 
U80 [26]. 
domain [6, 29, 30]. Within the past few years, three groups have resolved the X-ray 
crystal structure of a ~250 amino-acid fragment near the C-terminus of yeast and 
human Prp8 [27, 30, 34]. Although there are slight conformational differences between 
yeast and human structures, all three groups revealed the presence of an RNase H 
domain, which consists of two parts, the N-terminal subdomain with an RNase H fold 
and a C-terminal subdomain consisting of five alpha helices [6]. The human RNase H 
domain has a characteristic five parallel/antiparallel beta strands buttressed by two 
alpha helices [30] (Fig. 5). In addition to the aforementioned features, the crystal 
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structures also revealed the presence of an unusual beta finger that is unique to the 
RNase H domain of Prp8 [6, 30]. At the junction where the N-terminal RNase H domain 
juxtaposes the C-terminal alpha helices, a ~25 Å channel is formed, which is likely a 
double-stranded RNA binding pocket [6] (Fig. 5). In fact, cross-linking experiments have 
shown that the Prp8 RNase H domain interacts with the 5’ splice site [30]. 
 
Figure 5: Human RNase H domain. Left: The ribbon structure of human Prp81769-1990. Alpha helices and 
beta sheets are shown in red and yellow respectively. Sequence contains two domains; the N-terminal 
RNase H domain and the C-terminal cluster of alpha helices. The β2-β3 represents the beta finger unique 
to Prp8 RNase H domain. Right: Space-filling model of the corresponding yeast Prp8 domain showing 
possible interaction with the 5’ splice site of pre-mRNA. 
RNase H is a metalloenzyme that generally uses two metal ions coordinated by 
four conserved carboxylates to specifically cleave RNA that hybridizes to DNA; 
however, the RNase H domain of Prp8 has only has two aspartate residues (D1853 and 
D1854 in yeast and D1782 and D1781 in human) at the positions corresponding to two 
of the four metal-coordinating carboxylates [6, 30]. Moreover, no bound metal ions were 
observed in either human or yeast crystal structures [30, 34]; however, D1853A and 
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D1854A mutants showed a temperature-sensitive phenotype [30]. Therefore, this 
observation, together with the fact that the conserved aspartate residues lie in close 
proximity to the 5’ splice site, suggests that pre-mRNA catalysis may be carried out by 
two conserved aspartate residues and two metal-coordinating ligands in snRNA, making 
the catalytic components of the spliceosome a ribonucleoprotein. Alternatively, it is 
hypothesized that Prp8 is capable of bringing the catalytically important RNA 
components of the spliceosome together to facilitate the formation of the active-site 
conformation [24, 25], hence Prp8 is a protein cofactor for an RNA enzyme [32].  
 
Figure 6: The smFRET experiment setup. U2-U6 is immobilized to a quartz slide via biotin-streptavidin 
link. The donor (Cy3) and the acceptor (Cy5) are attached to U6. The U2-U6 conformational changes are 
measured based on the change in FRET between the donor and the acceptor.   
1.5: Splicing errors are attributed to many diseases.  Errors in splicing are correlated 
with a number of diseases, including various forms of cancer such as leukemia and 
ovarian cancer, neurodegenerative disorders like Parkinson’s disease, and genetic 
disorders like cystic fibrosis [35-39]. Therefore, understanding the detailed mechanism 
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and dynamics of the molecules involved in splicing is important to understand the 
underlying molecular mechanisms of related diseases. 
1.6: Sm-FRET can be used to study U2-U6 dynamics. Single-molecule fluorescence 
resonance energy transfer (smFRET) is a versatile technique that allows studies of the 
dynamics of biological molecules that are otherwise hidden in ensemble-average 
experiments [40]. SmFRET involves labeling the molecules with at least two 
fluorophores; the donor and the acceptor fluorophores, and only the donor is excited 
with an appropriate wavelength laser. During smFRET studies, it is important to reduce 
background fluorescence, and for this purpose our lab uses prism-based total internal 
reflection fluorescence (TIRF) microscopy. In TIRF, the laser reaches the prism at an 
angle greater than the critical angle, at which the incident beam is totally internally 
reflected and does not penetrate into the sample [40]. Instead, an evanescent wave is 
generated at the slide-solution interface. The evanescent wave only penetrates a few 
hundred nanometers (100-300 nm) into the solution, which then excites only the 
molecules close to the slide surface, and therefore reduces the background 
fluorescence [40]. 
In our study, a minimal U6 construct is labeled with Cy3 (donor) and Cy5 
(acceptor) fluorophores, and the donor is excited with a 532 nm laser (Fig. 6). 
Depending on the distance between the donor and the acceptor, some of the donor-
emitted energy is transferred to the acceptor, due to the fact that the Cy3 emission 
spectrum overlaps with the Cy5 absorption spectrum. The efficiency of the energy 
transfer is given by  
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where R is the distance between donor and acceptor, R0 is the Förster distance, i.e. the 
distance that corresponds to 50% efficient energy transfer. 
In our single-molecule FRET experiments, the intensities of the donor and the 
acceptor fluorophores are collected through the microscope objective and directed to a 
CCD camera in two separate channels. The apparent FRET value is given by 
     
  
        
 
where IA and ID are the intensities of the acceptor and the donor, respectively. The 
variation of FRET over time then allows the determination of the relative distances 
between the donor and the acceptor, which in turn provides valuable information about 
the structural dynamics of individual molecules. FRET can therefore be regarded as a 
molecular ruler to study the conformational dynamics within biological systems. 
  
11 
 
 
CHAPTER 2: Materials and methods 
2.1: RNA purification and labeling. RNA sequences (Table 1) were purchased from 
the Keck Foundation Resource Laboratory at the Yale University School of Medicine 
and purified and labeled as described [41, 42]. The 2’-hydroxyl protection groups were 
removed as described [41].  The RNAs were purified by denaturing gel electrophoresis 
(20% wt/vol polyacrylamide and 8 M urea) and diffusion eluted against elution buffer 
(0.5 M NH4OAc and 0.1 mM EDTA) overnight at 4 C, followed by chloroform extraction 
and ethanol precipitation. The U6 was labeled with Cy5 (GE Healthcare). The labeled 
RNA was precipitated by ethanol precipitation and purified by C8 column reverse-phase 
HPLC to remove unlabeled and non-deprotected RNA. RNA concentrations were 
measured by UV-Vis absorbance at 260 nm. 
Name  Description Sequence 
U6 X = dT with C6 
amino linker for 
Cy5 labeling 
Cy3-AUACAGAGAUGAUCAGCAGUUCCCCXGCAUAAG 
GAUGAACCGUUUUACAAAGAGAU-Biotin 
U6F X = Fluorescein XAUACAGAGAUGAUCAGCAGUUCCCCXGCAUAAG 
GAUGAACCGUUUUACAAAGAGAU 
U6-1 X = dT with C6 
amino linker for 
Cy3 labeling 
Cy5-AUACAGAGAUGAUCAGCAGUUCCCCX 
U6-2 X = Δ/G/C/A 
Z = Biotin 
AGGAXGAACCGUUUUACAAAGAGAUZ 
U2  UAUGAUGUGAACUAGAUUCGGUUUUCCGUUUCUCUA 
 
Table 1: RNA sequences used in the study. The symbol Δ denotes U80 deletion. 
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2.2: MALDI-MS Experiment. Matrix-assisted laser desorption ionization-mass 
spectrometry (MALDI-MS) was carried out for Cy3-U6 sample to confirm the position of 
the modified nucleotide and therefore the position of Cy5. The RNA sequence (300 
pmol) was RNase T1 digested for 15 minutes to produce smaller fragments. The 
molecular weights of the fragments were calculated by using the Mongo 
Oligo Mass Calculator v2.06. After RNase T1 digestion, the reaction was quenched in 
dry-ice, dried and dissolved in 1 µL water. A saturated MALDI matrix solution was 
prepared by mixing 3-hydroxypicolinic acid (HPA) in 50% acetonitrile. The MALDI matrix 
(1 µL), 100 mM ammonium citrate (0.5 µL) and RNase T1 digested RNA sample (1 µL) 
were mixed on the MALDI plate in the given order.  The spot was dried and used in 
MALDI experiment. A representative spectrum for Cy3-U6 is shown in Figure 7. The 
peak that appears at 2654.716 corresponds to the fragment with the amino-modified 
nucleotide used for Cy5 labeling. In addition to the fragment with the modified 
nucleotide, most of the other digested fragments were also observed within a 
reasonable error (Table 2). 
 
Figure 7: The MALDI result reveals the mass of the fragment that is used for Cy5 labeling. The peak that 
appears at 2654.716 is the mass of the fragment containing the modified nucleotide for Cy5 labeling. The 
peaks at 1963.249 and 2391.170 are two other resulting fragments after RNase T1 digestion. 
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Fragment Sequence Expected mass Expected mass 
(without 3'-
Phosphate ) 
Observed 
mass 
A1:G6 pAUACAGp 3267.597 3249.579 N/O* 
A7:G8 AGp 692.433    674.418 693.985 
A9:G11    AUGp 998.602 980.587 999.348 
A12:G16   AUCAGp 1632.995 1614.980 1633.940 
C17:G19 CAGp 997.617 979.602 999.348 
U20:G26 UUCCCCGp 2654.708 2636.693 2654.716 
C27:G32 CAUAAGp 1962.204   1944.189 1964.155 
G33:G33    Gp 363.224 345.209 N/O* 
A34:G36    AUGp 998.602    980.587 999.348 
A37:G41   AACCGp 1632.010   1613.995 1633.940 
U42:G51   UUUUACAAAGp 3209.919   3191.904 3211.360 
A52:G53    AGp 692.433   674.418 693.985 
A54:U59   AUUUAU 2390.739    2391.170 
  
Table 2: The expected and the observed masses from MALDI-MS experiments for the fragments resulted 
after RNase T1 digestion. All the masses are observed within a 0.5% error. * Not observed. 
2.3: Protein purification. The plasmid pMAL-c2x (containing the amino acid sequence 
1806-2413 of Prp8 with maltose binding protein (MBP) fused to the carboxyl terminus of 
Prp8 fragment) was obtained from McMillan’s lab at the University of Alberta. The 
plasmid was inserted into a BL21 expression vector and expressed the cells at 22 °C to 
an optical density of 0.4-0.5, at which point the cells were induced by adding 0.3 µM 
IPTG, followed by overnight incubation. The culture was centrifuged, to collect the cell 
pellet. The cells were lysed by dissolving the pellet in the lysis buffer (20 mM Tris-Cl pH 
8.0, 100 mM KCl, 5 mM BME). The supernatant containing proteins was obtained and 
passed through the amylose column. Prp8 binds to the amylose resin via MBP. The 
protein was then eluted with the elution buffer (20 mM Tris-Cl pH 8.0, 100 mM KCl, 5 
mM BME, 10 mM maltose) and cleaved by the TEV protease to remove MBP. Anion-
exchange column (Q-column) was used to separate MBP from Prp8. [30]. The SDS gel 
containing the purified Prp8 fragment is shown in the figure 8. 
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Figure 8: The 8% SDS gel for Prp8 purification. Left: EZ-Run, pre-stained protein ladder. Right: Prp81806-
2413. The size of Prp8 Prp81806-2413 is 69 kDa. 
2.4: Gel-shift assays. The two RNAs, U2 (4 µM) and U6 (2 µM), were annealed (50 
mM Tris-Cl pH 7.5, 100 mM NaCl, 10 mM MgCl2) by heating at 94 °C for 45 s, followed 
by 20 min incubation at room temperature. Prp8 was added and incubated for 30 min to 
allow it to interact with the U2-U6 complex. An equal volume of 40% glycerol was added 
to the reaction mixture and the samples were run on a native gel (8% acrylamide 40% 
w/v) using a 50 mM Tris-acetate pH 7.5, 10 mM magnesium acetate, 100 mM sodium 
acetate and 5 mM DTT buffer at 4 °C for 8 h at 100 V. The gel was fluorescence imaged 
using a Typhoon imager (GE Healthcare) by exciting the Cy3 donor fluorophore at 532 
nm. 
2.5: Fluorescence anisotropy experiments. Anisotropy experiments were carried out 
using a spectrofluorometer with automated polarizers (Varian, Carry Eclipse). The U6 
RNA with 5’ fluorescein (25 nM) and U2 RNA (50 nM) were mixed in a standard buffer 
(50 mM Tris-HCl pH 7.5, 100 mM NaCl, and 10 mM MgCl2) and heated at 94 °C for 45 s 
and then annealed at room temperature for 20 min. Anisotropy was measured for Prp8 
concentration from 0-60 µM. Fluorescein was excited at 490 nm (5 nm bandwidth), 
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parallel (Iǁ) and perpendicular ( ) emission intensities were measured at 520 nm (5 nm 
bandwidth). Fluorescence anisotropy (r) is given by  
  
          
            
where G is an instrument-dependent correction factor. 
2.6: Single-molecule experiments. The experimental setup shown in Figure 6 was 
used. Single-molecule FRET (smFRET) experiments were performed as described 
below. The U2 (4.0 µM) and U6 (2.0 µM) RNAs were annealed in standard buffer (50 
mM Tris-HCl pH 7.5, 100 mM NaCl, and 10 mM MgCl2 in saturating trolox) by heating a 
10 µL solution at 94 °C for 45 s and cooling at room temperature for 20 min.  The U2-U6 
complex was diluted to 25 pM and immobilized onto a streptavidin-coated quartz slide 
via biotin to generate a surface density of ~0.1 molecules/µm2. In order to prevent non-
specific protein binding, the quartz slides were treated with polyethylene glycol (PEG) 
during slide preparation. The protein was injected along with an oxygen scavenging 
system (OSS) (10 nM Protocatechuic acid (PCA) and 2.5 mM Protocatechuate-3,4-
dioxygenase (PCD) and standard buffer) and the slide was incubated for 30 min. The 
donor fluorophore was excited in a home-built total internal reflection microscope with a 
532 nm laser (3 mW, Spectra-Physics Excelsior). The donor and the acceptor 
emissions were separated using appropriate dichroic mirrors (610DCXR, Chroma) and 
detected as two side-by-side images on a back-illuminated electron-multiplied CCD 
camera (Andor ixon). 
  

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CHAPTER 3: Results and discussion 
 
Single-molecule experiments with U2 and U6 RNAs (Table 1) confirm previous data, 
that the U2-U6 complex adopts at least three FRET states, of which ~0.2 and ~0.4 are 
well populated while the ~0.6 state is only transiently populated at 10 mM Mg2+ 
concentration (Fig. 9). Previous SM data showed that increasing Mg2+ stabilizes the low 
  
Figure 9: U2-U6 dynamics in the absence of Prp8. Left: Intensity (top) and the corresponding FRET 
trajectory (bottom) of a single U2-U6 complex showing all three FRET states. Donor and acceptor 
intensities are shown in green and red, respectively. Top right: The FRET histogram drawn with more 
than one-hundred molecules. At 10 mM Mg
2+
 0.4 and 0.2 FRET states are mostly populated while 0.6 
FRET state is only transiently populated. Bottom right: U2-U6 construct used in the study. 
 
FRET states, thereby separating the U6 ISL from the ACAGAGA sequence; however, if 
the metal ion bound at the position U80 of U6 has a role in catalysis or related function, 
one would expect the opposite, i.e., upon Mg2+ binding, U6 ISL comes closer to the 
ACAGAGA sequence and therefore increase the high FRET state. Many groups 
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therefore suggest that in vivo, proteins may be involved in stabilizing the favorable 
conformations important for efficient splicing. Since the RNase H domain of Prp8 protein 
interacts with catalytically important snRNAs and the pre-mRNA, we propose that Prp8 
may be involved in the high FRET state stabilization. To study the effect of Prp8 on U2-
U6 conformations, smFRET experiments were carried out in the presence of yeast 
Prp81806-2413 expressing both the RNase H and MPN domains. 
3.1: Prp81806-2413 binds our U2-U6 complex. Gel-shift assays from the McMillan lab 
showed that the RNase H domain of human Prp8 binds to an RNA sequence that forms 
a four-helix junction similar to U2, U6 and the 5’ splice site interaction of the 
spliceosome [30]. In order to test whether yeast Prp81806-2413 binds our U2-U6 construct, 
gel-mobility-shift assays and anisotropy experiments were carried out. Even though the 
binding affinity is low (~5% when Prp8 is 70 μM), the gel picture shows clearly that 
Prp81806-2413 binds our U2-U6 construct (Fig. 10). Compared to the unbound U2-U6, the 
bound U2-U6 complex has high FRET, indicating that Prp8 might be involved in 
stabilizing the high FRET state as we had hypothesized. The poor binding in the gel 
might result from instability of the U2-U6/ Prp81806-2413 complex in the gel. Therefore 
alternative methods were used to measure the binding affinity. 
3.2: Fluorescence anisotropy measurements reveal Prp81806-2413 binding to U2-U6 
complex. Fluorescence anisotropy can be used to monitor protein-nucleic acid 
interaction when one of the components is labeled with a fluorophore [43]. Anisotropy 
measurements compare the orientation of fluorophores between absorption and 
emission by monitoring emission intensity parallel and perpendicular to excitation. If a 
fluorophore attached to the molecule of interest interacts with a large molecule such as 
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Figure 10: Prp8 weakly binds U2-U6. Top: Gel-mobility-shift assay with Prp81806-2413 and U2-U6 complex. 
Lane 1: U6, Lane 2: U2-U6 complex, Lane 3-11: U2-U6 complex and Prp8 (0.01, 0.1, 1, 5, 10, 20, 40, 60, 
70 µM respectively). Bottom: Fitting the anisotropy values against Prp8 concentration to a quadratic 
equation gives a KD value of ≥30 µM. 
a protein, the rate of fluorophore tumbling decreases, and hence the anisotropy 
increases. In our study, we tested the change in anisotropy for a fluorescein-labeled U2-
U6 complex with increasing Prp8 concentration. Supporting our native gel data, the 
results show that the anisotropy is increased with Prp8 concentration (Fig. 10). An 
estimated dissociation constant (KD) of ≥30 μM was obtained by fitting the data to the 
quadratic equation, 
                       
                                                       
        
   
where r0, rmax, RNA0, and KD are the lowest anisotropy value, highest anisotropy value, 
RNA concentration, and dissociation constant, respectively. We were not able to reach 
saturation in these experiments because we are limited by the concentration of the 
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protein stock. Compared to the gel-shift assays, anisotropy experiments reveal more 
Prp8 binding to U2-U6, supporting the idea that the U2-U6/Prp8 interaction is not stable 
during gel-shift assays. 
3.3: Single-molecule studies reveal Prp81806-2413 stabilizes the high FRET states. 
Supporting our hypothesis, that Prp81806-2413 is involved in stabilizing the high FRET 
conformation, we observed a higher percentage of static and dynamic molecules at ≥0.6 
FRET state (Fig. 11). Interestingly with increasing Prp8 concentrations, molecules with 
FRET states ~0.8 and ~1.0 were also observed (Fig. 10). Three FRET histograms 
 
Figure 11: Characteristic molecules at  ≥0.6 FRET states  at 10  mM Prp8  concentration. Top left: static 
molecules at 0.6 FRET state, top right: fast dynamics between ~0.6 and ~0.2 FRET states, bottom left: 
dynamics between ~0.4 and ≥0.6 FRET states, bottom right: dynamics between ~0.4 and ~1.0 FRET 
states. 
drawn from the smFRET experiments in the presence of Prp8 (0.001, 1 and 20 µM) are 
shown in Figure 12. From the histograms, it is clear that Prp8 increases the high FRET 
population  compared  to the  low and  intermediate  FRET  states. The  fraction of  ≥0.6  
20 
 
 
  
Figure 12: Prp8 stabilizes the high FRET states of U2-U6. Left: Higher Prp8 concentrations result a broad 
peak that extends from FRET 0.6-1.0. This may be because Prp8 brings the U6 ISL close to the 
ACAGAGA sequence and therefore Cy3 and Cy5 come very close together and most of the energy is 
transferred from the donor to the acceptor. The broad peak may result due to the fast dynamics at high 
Prp8 concentration. Top right: Fitting the fraction of molecules with ≥0.6 FRET state against Prp8 
concentration to a modified Hill equation gives a KD value of ≥10 µM. Bottom right: Control SM experiment 
with PTB at 20 µM concentration.   
FRET states was calculated by integrating the histograms and values were plotted 
against Prp8 concentration (Fig. 12). Although we do not reach saturation, it is clear 
that with increasing Prp8 concentration, the ≥0.6 FRET state is increased. A 
dissociation constant of ≥10 µM was estimated by fitting the data to a modified Hill 
equation, 
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where f0, fmax, n, X and KD are the initial fraction of molecules with ≥0.6 FRET state, the 
final fraction of molecules with ≥0.6 FRET state, the Hill coefficient, Prp8 concentration, 
and the dissociation constant, respectively. The estimated KD is comparable with a 
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dissociation constant from a previous study for a closely related Prp8 domain and RNA 
sequence [30]. In order to test the specificity of Prp8 in stabilizing the high FRET states, 
a control experiment was carried out with the protein PTB (Polypyrimidine Tract 
Binding) at 20 µM concentration. The corresponding histogram shows (Fig. 12) that the 
high FRET states were not increased with PTB indicating that Prp8 specifically 
increases the high FRET states of U2-U6 complex.  
 
Figure 13: Experiments with U6 which are mutated/deleted at the position U80 in the presence of Prp8. 
The high FRET states are considerably rescued when the U80 is replaced to a different nucleotide than 
when it is deleted. 
3.4: Prp8 stabilizes the high FRET states of the U80 mutants. Previous studies from 
our lab showed that the U2-U6 complex forms three base-triple interactions (G86-
C61·U80, U87-G60·G52 and U88-A59·A53) that are important in the stabilization of the 
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high FRET state [25] (Fig. 4). In order to investigate the contribution of these base 
triples and Prp8, separately on the stabilization of the high FRET state, single-molecule 
experiments were carried out using U80 mutated U6 sequences in the presence and 
absence of Prp8 (20 µM) (Fig. 13). A three-piece U2-U6 constructs were used in the 
study (The GCAUA penta-loop was deleted from the minimal U6 in Figure 8 and 
therefore U6 comes in two pieces). 
The high FRET stabilization is more apparent when U80 is replaced with G/C/A 
than  when it is deleted. This may indicate that the high FRET states stabilization by 
Prp8 mainly depends on the presence of a nucleotide rather than its identity at the U80 
position. Our results show that Prp8 considerably stabilizes high FRET states of U80G. 
However, previous studies have shown that U80G has a lethal phenotype [21]. 
Therefore we hypothesized that not only the high FRET conformation, but also the 
identity of the nucleotide is important for the splicing activity. These nucleotides might 
have crucial functions such as metal ion binding and/or structural effect. 
In summary, the RNase H domain of Prp8 interacts with the minimal U2-U6 
construct weakly and it is involved in stabilizing the high FRET state. Furthermore, in 
addition to the ~0.6 high FRET state that is observed at 10 mM MgCl2 in a protein-free 
environment, at high Prp8 concentration, a broad band that extends from FRET 0.6-1.0 
was reported (Fig. 12). This may due to the fact that Prp8 brings the U6 ISL close in 
proximity to the ACAGAGA sequence and AGC triad (Fig. 14) and therefore most of the 
energy is transferred from the donor to the acceptor. 
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Figure 14: The proposed model for Prp8 in the vicinity of U2-U6. In the presence of Mg
2+
, U2-U6 favors 
the low FRET states and therefore the high FRET states and transiently populated. However, in the 
presence of Prp8, at the same Mg+ concentrations, the high FRET states are dominated. 
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CONCLUSIONS 
 
We have carried out sm-FRET experiments to study the effect of Prp8 on the 
conformational dynamics of a minimal U2-U6 construct. In the absence of Prp8, low and 
intermediate U2-U6 FRET states are more populated while the high FRET states are 
only transiently sampled. In the presence of Prp8, however, the high FRET states are 
dominant. A broad band that extends from 0.4-1.0 results at high Prp8 concentration, 
possibly because Prp8 transiently interacts and partially unwinds helix III resulting in 
faster dynamics. Moreover, the results with the U6 mutants show that Prp8 can at least 
partially rescue the high FRET states of U80A, U80G and U80C, while it has only a 
minimal effect on U80Δ. Therefore, we suggest that the presence of a nucleotide, rather 
than its identity is important in stabilizing the high FRET states by Prp8 and hence the 
action of Prp8 is robust. As U80G is lethal [21], we suggest that in addition to the high 
FRET states, the identity of the nucleotide is important for the activity. Overall, based on 
our results we propose a model for the action of the RNase H domain of Prp8 in the 
vicinity of U2-U6 (Fig. 14). The increase in time spent in the high FRET states in the 
presence of Prp8 suggests that Prp8 may assist in bringing the U6 ISL in close proximity 
to the U6 ACAGAGA sequence, and therefore, placing the catalytically important metal 
ion at U80 close to the 5’ splice site.  
Overall, results in this study enable us to understand the dynamics of the U2-U6 
complex at the catalytic center of the spliceosome. The study is exciting as the results 
from this thesis may lead towards the discovery of novel therapeutics to cure human 
diseases that arise from splicing errors. 
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CHAPTER 4: Future directions 
 
Our data suggest that Prp8 stabilizes the U2-U6 high FRET conformations. In 
order to further investigate the role of Prp8 in modulating the U2-U6 conformations, we 
propose to perform smFRET experiments using mutant Prp8 and U2-U6. The beta-
finger of the RNase H of Prp8 contains both the first- and second- step alleles [33]. It is 
hypothesized that the first-step complex is stabilized by the first-step alleles, while it is 
destabilized by the second-step alleles [33]. We propose to carry out smFRET 
experiments with the first- and second-step alleles of Prp8 (Fig. 15) to study their 
effects on U2-U6 dynamics. We expect to observe different U2-U6 dynamics for 
different alleles, in particular, more high FRET state for the first-step alleles than for the 
second-step alleles.  
 
Figure 15: The first- (V1860D and T1865K) and second-step (H1863E and V1870N) alleles of Prp8. 
Shown in purple are D1853 and D1854 which form an incomplete active site.  
The D1854 is one of the aspartate residues that form an incomplete active site of 
the RNase H domain of Prp8 and the D1854A mutation has a temperature sensitive 
phenotype (Fig. 15). We propose to perform single-molecule experiments with Prp8-
D1854A to test the effect of the mutation on U2-U6 dynamics. With the mutant Prp8, we 
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expect to observe U2-U6 dynamics that are different from the U2-U6 dynamics in the 
presence of the wild-type Prp8. 
               
Figure 16: The proposed mutants for U2-U6. Left: The minimal U6 showing the mutations at U80 and 
G52. Left: The six-fold U6 mutant that favors the formation of four-helix junction and the A91G mutation of 
U6 that favors the formation of the three-helix junction. 
We propose to carry out smFRET experiments with a G52C U6 mutant that 
disrupts the U87-G60·G52 base triple (Fig. 16). In the absence of Prp8, the G52C 
mutation eliminates the high FRET state. It is also important to note that G52 is 
protected from RNase T1 and RNase A digestion in the presence of saturating 
concentration of the RNase H domain of human Prp8, indicating that Prp8 interacts with 
G52 [30]. 
A six-fold mutant (Fig. 16) of U6 that prevents the formation of helix IB while 
maintaining the stability of the U6 ISL has previously shown that molecules mostly exist 
in the ~0.4 FRET state and occasionally go to the ~0.6 FRET state [25]. On the other 
hand, the U6 A91G mutation (Fig. 16) favors the formation of helix IB by extending helix 
II and thereby stabilizing it relative to the U2 stem I [25]. Therefore, this six-fold mutant 
U6 (the last three base pairs of the extended U6 ISL are swapped) and A91G U6 will be 
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used in our study to test the ability of Prp8 to increase the high FRET population when 
the U2-U6 complex preferentially exists either in the ~0.2 or ~0.4 FRET state.  
We will also use the RNase H domain of human Prp8 to study the effect of the 
protein on the human U2-U6 complex, and hence, compare the effects of the RNase H 
domain of human and yeast Prp8 on the U2-U6 dynamics. Altogether the results from 
this study will explain the role of RNase H domain of both human and yeast Prp8 in 
stabilizing U2-U6 conformations during splicing catalysis.   
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ABSTRACT 
THE SPLICEOSOMAL PROTEIN PRP8 STABILIZES A COMPACT CONFORMATION 
OF THE U2-U6 COMPLEX 
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Degree: Master of Science  
The spliceosome is a large, RNA-protein complex that catalyzes pre-mRNA 
splicing during mRNA maturation. The RNA components (small nuclear RNA; snRNAs) 
of the spliceosome have been well studied and are believed to be involved in the 
splicing catalysis. Although proteins are essential for splicing, they may not be directly 
involved in catalysis. Among hundreds of proteins, Prp8 is the only protein that interacts 
with all of the catalytically important snRNAs. Therefore, it is hypothesized that Prp8 
may catalyze splicing either by directly participating in catalysis or by stabilizing the 
conformation of the catalytically active spliceosome. In order to test whether or not Prp8 
stabilizes the active-site conformation, we carried out single-molecule fluorescence 
resonance energy transfer (smFRET) experiments with catalytically important snRNAs 
U2 and U6 and Prp8. We observed that in the presence of Prp8, the population of the 
high FRET conformation of U2-U6 that is thought to be the active conformation 
increased indicating that one of the functions of Prp8 would be to stabilize the active site 
conformation of the spliceosome.  
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